Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous altepla se in acute ischaemic stroke(ECASS Ⅱ).Recombinant tissue-type plasminogen activator(Alteplase)for ischemic stroke 3 to 5 hours after symptom onset . ......